Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Linear and Conformational B Cell Epitope Prediction of the Her 2 Ecd-Subdomain Iii by in Silico Methods Publisher



Mahdavi M1 ; Mohabatkar H2 ; Keyhanfar M2 ; Dehkordi AJ1 ; Rabbani M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Biotechnology, Faculty of Advanced Sciences and Technologies, University of Isfahan, Isfahan, Iran

Source: Asian Pacific Journal of Cancer Prevention Published:2012


Abstract

Human epidermal growth factor receptor 2 (HER2) is a member of the epidermal growth factor receptor family of receptor tyrosine kinases that plays important roles in all processes of cell development. Their overexpression is related to many cancers, including examples in the breast, ovaries and stomach. Anticancer therapies targeting the HER2 receptor have shown promise, and monoclonal antibodies against subdomains II and IV of the HER2 extra-cellular domain (ECD), Pertuzumab and Herceptin, are currently used in treatments for some types of breast cancers. Since anti HER2 antibodies targeting distinct epitopes have different biological effects on cancer cells; in this research linear and conformational B cell epitopes of HER2 ECD, subdomain III, were identified by bioinformatics analyses using a combination of linear B cell epitope prediction web servers such as ABCpred, BCPREDs, Bepired, Bcepred and Elliprro. Then, Discotope, CBtope and SUPERFICIAL software tools were employed for conformational B cell epitope prediction. In contrast to previously reported epitopes of HER2 ECD we predicted conformational B cell epitopes P1C: 378-393 (PESFDGDPASNTAPLQ) and P2C: 500-510 (PEDECVGEGLA) by the integrated strategy and P4: PESFDGD-X-TAPLQ; P5: PESFDGDP X TAPLQ; P6: ESFDGDP X NTAPLQP; P7: PESFDGDP-X-NTAPLQ; P8: ESFDG-XX-TAPLQPEQL and P9: ESFDGDP-X-NTAPLQP by SUPERFICIAL software. These epitopes could be further used as peptide antigens to actively immune mice for development of new monoclonal antibodies and peptide cancer vaccines that target different epitopes or structural domains of HER2 ECD.
Related Docs
View other Related Docs
1. In Silico Design of Discontinuous Peptides Representative of B and T-Cell Epitopes From Her2-Ecd As Potential Novel Cancer Peptide Vaccines, Asian Pacific Journal of Cancer Prevention (2013)
2. Production and Characterization of New Anti-Her2 Monoclonal Antibodies, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy (2015)
3. Immunization With a Novel Chimeric Peptide Representing B and T Cell Epitopes From Her2 Extracellular Domain (Her2 Ecd) for Breast Cancer, Tumor Biology (2014)
4. Exploring the Cancer-Testis Antigen Boris to Design a Novel Multi-Epitope Vaccine Against Breast Cancer Based on Immunoinformatics Approaches, Journal of Biomolecular Structure and Dynamics (2022)
5. In Silico Designing Breast Cancer Peptide Vaccine for Binding to Mhc Class I and Ii: A Molecular Docking Study, Computational Biology and Chemistry (2016)
6. In Silico Analysis of Synaptonemal Complex Protein 1 (Sycp1) and Acrosin Binding Protein (Acrbp) Antigens to Design Novel Multiepitope Peptide Cancer Vaccine Against Breast Cancer, International Journal of Peptide Research and Therapeutics (2019)
7. Exploring the Out of Sight Antigens of Sars-Cov-2 to Design a Candidate Multi-Epitope Vaccine by Utilizing Immunoinformatics Approaches, Vaccine (2020)
8. New Insights Into Affinity Proteins for Her2-Targeted Therapy: Beyond Trastuzumab, Biochimica et Biophysica Acta - Reviews on Cancer (2020)
Experts (# of related papers)
View all Related Experts
Vajihe Akbari (6)
Abbas Jafarian (6)
Other Related Docs
9. Evaluation of Immunohistochemistry Technique in Detecting Her2 Overexpression in Invasive Ductal Breast Carcinoma Using Fluorescence In-Situ Hybridization Method, Journal of Isfahan Medical School (2016)
10. Immunoinformatic Analysis of Calcium-Dependent Protein Kinase 7 (Cdpk7) Showed Potential Targets for Toxoplasma Gondii Vaccine, Journal of Parasitology Research (2021)
11. Functional Expression of a Single-Chain Antibody Fragment Against Human Epidermal Growth Factor Receptor 2 (Her2) in Escherichia Coli, Journal of Industrial Microbiology and Biotechnology (2014)
12. In-Silico Design of a New Multi-Epitope Vaccine Candidate Against Sars-Cov-2, Acta Virologica (2023)
13. Development of Polyepitopic Immunogenic Contrast Against Hepatitis C Virus 1A-6A Genotype by in Silico Approach, Biomedical and Biotechnology Research Journal (2020)
14. Improved Biological Activity of a Single Chain Antibody Fragment Against Human Epidermal Growth Factor Receptor 2 (Her2) Expressed in the Periplasm of Escherichia Coli, Protein Expression and Purification (2015)
15. Bispecific Antibodies in Colorectal Cancer Therapy: Recent Insights and Emerging Concepts, Immunotherapy (2021)
16. Identification of B and T Cell Epitope Based Peptide Vaccine From Igf-1 Receptor in Breast Cancer, Journal of Molecular Graphics and Modelling (2017)
17. Novel Sars-Cov2 Poly Epitope Phage-Based Candidate Vaccine and Its Immunogenicity, Research in Pharmaceutical Sciences (2024)
18. Evaluation of Humoral and Cellular Immune Responses Against Vibrio Cholerae Using Oral Immunization by Multi-Epitope-Phage-Based Vaccine, International Immunopharmacology (2024)
19. A Rapid and Sensitive Method for Ephb4 Identification As a Diagnostic and Therapeutic Biomarker in Invasive Breast Cancer, Journal of Cancer Research and Therapeutics (2016)
20. Optimization of a Single-Chain Antibody Fragment Overexpression in Escherichia Coli Using Response Surface Methodology, Research in Pharmaceutical Sciences (2015)
21. Comparing Efficacy and Safety of P013, a Proposed Pertuzumab Biosimilar, With the Reference Product in Her2-Positive Breast Cancer Patients: A Randomized, Phase Iii, Equivalency Clinical Trial, BMC Cancer (2022)
22. Efficacy of Co-Immunization With the Dna and Peptide Vaccines Containing Sycp1 and Acrbp Epitopes in a Murine Triple-Negative Breast Cancer Model, Human Vaccines and Immunotherapeutics (2021)
23. Design and Construction of Scfv-Pe35kdel As a Novel Immunotoxin Against Human Epidermal Growth Factor Receptor 2 for Cancer Therapy, Biotechnology Letters (2023)
24. Ephb4 Tyrosine Kinase Stimulation Inhibits Growth of Mda-Mb-231 Breast Cancer Cells in a Dose and Time Dependent Manner, Disease Markers (2013)
25. Design of Multivalent-Epitope Vaccine Models Directed Toward the World’S Population Against Hiv-Gag Polyprotein: Reverse Vaccinology and Immunoinformatics, PLoS ONE (2024)
26. Computational Design of Newly Engineered Darpins As Her2 Receptor Inhibitors for Breast Cancer Treatment, Research in Pharmaceutical Sciences (2023)
27. Functional and Structural Characterization of Ebola Virus Glycoprotein (1976-2015)-An in Silico Study, International Journal of Biomathematics (2017)
28. Discordance of Human Epidermal Growth Factor Receptor-2 Expression in Primary Breast Cancer and Related Axillary Lymph Node Metastasis, Asian Journal of Pharmaceutics (2018)
29. Toxoplasma Gondii Tyrosine-Rich Oocyst Wall Protein: A Closer Look Through an in Silico Prism, BioMed Research International (2021)
30. An Immunohistochemistry Study of Tissue Bcl-2 Expression and Its Serum Levels in Breast Cancer Patients, Annals of the New York Academy of Sciences (2008)
31. Investigation of Her-2 Expression and Its Correlation With Clinicopathological Parameters and Overall Survival of Esophageal Squamous Cell Carcinoma Patients, Iranian Journal of Pathology (2020)
32. Therapeutic Potential of Plk1, Kif4a, Cdca5, Ube2c, Cdt1, Ska3, Aurkb, and Pttg1 Genes in Triple-Negative Breast Cancer: Correlating Their Expression With Sensitivity to Gsk 461364 and Ikk 16 Drugs, Biochemical Genetics (2024)
33. Multicentricity in Different Molecular Subtypes of Breast Cancer: A Cross-Sectional Study in Isfahan, Advanced Biomedical Research (2023)
34. Multi-Epitope Vaccine Against Cystic Echinococcosis Using Immunodominant Epitopes From Ega31 and Egg1y162 Antigens, Informatics in Medicine Unlocked (2020)
35. Development of a Chimeric Vaccine Candidate Based on Toxoplasma Gondii Major Surface Antigen 1 and Apicoplast Proteins Using Comprehensive Immunoinformatics Approaches, European Journal of Pharmaceutical Sciences (2021)
36. In Silico Analysis of Transmembrane Protein 31 (Tmem31)Antigen to Design Novel Multiepitope Peptide and Dna Cancer Vaccines Against Melanoma, Molecular Immunology (2019)
37. Validity of Immunohistochemistry Method in Predicting Her-2 Gene Status and Association of Clinicopathological Variables With It in Invasive Breast Cancer Patients, APMIS (2016)
38. Computational Clues of Immunogenic Hotspots in Plasmodium Falciparum Erythrocytic Stage Vaccine Candidate Antigens: In Silico Approach, BioMed Research International (2022)